Cancer Drug Encyclopedia
Approved oncology medications — what they treat, how they work and key safety information.
Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL), Mantle Cell Lymphoma, Waldenström's Macroglobulinemia.
Targeted treatment of solid tumors and hematologic malignancies.
KRAS G12C-mutated Non-Small Cell Lung Cancer and advanced Colorectal Cancer.
Hodgkin Lymphoma, CD30-expressing T-cell lymphomas, Urothelial Carcinoma, Cervical Cancer, or Diffuse Large B-cell Lymphoma.
HER2-positive or HER2-low metastatic Breast Cancer, HER2-mutant Non-Small Cell Lung Cancer, and Gastric Adenocarcinoma.
Breast Cancer, Small Cell Lung Cancer, Colorectal Cancer, Ovarian Cancer, and Acute Leukemias.
Approved for use in oncology care according to FDA-approved indications.
Relapsed or refractory B-cell Acute Lymphoblastic Leukemia, Large B-cell Lymphoma, Mantle Cell Lymphoma, or Multiple Myeloma.
EGFR-mutated Non-Small Cell Lung Cancer (NSCLC).
Approved for use in oncology care according to FDA-approved indications.
Deleterious BRCA-mutated or HRD-positive Ovarian, Breast, Pancreatic, and Prostate Cancers.
Prevention and management of chemotherapy-induced and radiation-induced nausea and vomiting (CINV).